Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
1.050
-0.040 (-3.67%)
At close: Dec 5, 2025, 4:00 PM EST
1.020
-0.030 (-2.86%)
After-hours: Dec 5, 2025, 7:31 PM EST

Basel Medical Group Cash Flow Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-12.092.071.781.98
Depreciation & Amortization
1.180.530.560.58
Asset Writedown & Restructuring Costs
11.15-0.05-
Provision & Write-off of Bad Debts
-0.44-0.010.160.03
Other Operating Activities
-1.07-0.08-0.230.13
Change in Accounts Receivable
-7.28-0.420.540.01
Change in Inventory
-0.30.02-0.020
Change in Accounts Payable
4.340.39-0.220.06
Change in Other Net Operating Assets
0.18---
Operating Cash Flow
-4.342.512.62.79
Operating Cash Flow Growth
--3.49%-6.89%-
Capital Expenditures
-11.04-0.01-0.01-0.09
Investment in Securities
-0---
Investing Cash Flow
-11.04-0.01-0.01-0.09
Short-Term Debt Issued
10.951.42--
Long-Term Debt Issued
4--1.03
Total Debt Issued
14.951.42-1.03
Short-Term Debt Repaid
-0.11-0--10.86
Long-Term Debt Repaid
-9.24-2.92-2.94-3.09
Total Debt Repaid
-9.35-2.92-2.94-13.95
Net Debt Issued (Repaid)
5.6-1.5-2.94-12.92
Issuance of Common Stock
9.75---
Other Financing Activities
1.56-0.270-
Financing Cash Flow
16.91-1.77-2.94-12.92
Foreign Exchange Rate Adjustments
-0.5---
Net Cash Flow
1.030.73-0.35-10.22
Free Cash Flow
-15.392.52.592.7
Free Cash Flow Growth
--3.56%-4.07%-
Free Cash Flow Margin
-127.08%23.97%26.61%25.37%
Free Cash Flow Per Share
-0.820.150.160.17
Cash Interest Paid
0.20.410.240.32
Cash Income Tax Paid
0.650.180.290.03
Levered Free Cash Flow
3.951.711.89-
Unlevered Free Cash Flow
4.071.822.04-
Change in Working Capital
-3.08-00.290.08
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q